rituximab,cyclophosphamide,doxorubicin,vincristine,prednisolone 
not tagged
['ritux', 'rituximab']
great talk on post-transplant lymphoproliferative disease (ptld) - worth trialing reduction of immunosuppression
- rituximab single-agent effective in &gt;25% of patients
- nice schema for response-adapted escalation to chop-like chemo #17icml #icml 
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem